The development of a brain tumor in a study participant led regulators to suspend a Hurler syndrome therapy in early testing ...

Eli Lilly (NYSE: LLY) announced a global research collaboration with Seamless Therapeutics to develop programmable gene ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Key opportunities in the gene therapy market include treating genetic disorders and cancer, driven by rising FDA approvals and biotechnological advancements. The in vivo segment, cancer treatments, ...

Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.

A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

Fred Hutchinson researchers are testing a simple idea with surprisingly big potential: a special type of foam that makes gene therapy more efficient.

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Gene therapy represents an innovative approach to treating cancer by directly modifying the genetic material within tumour cells, thereby utilising molecular mechanisms to inhibit tumour growth or ...

Sarepta stock jumped early Monday after the company unveiled three-year test results for its embattled gene therapy, Elevidys ...